Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Receivables (2023 - 2025)

Vsee Health's Receivables history spans 3 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Receivables rose 25.69% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $2.8 million, up 25.69%, while the annual FY2025 figure was $2.8 million, 25.69% up from the prior year.
  • Receivables reached $2.8 million in Q4 2025 per VSEE's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.9 million in Q3 2025 to a low of $603480.0 in Q4 2023.
  • Average Receivables over 3 years is $2.0 million, with a median of $2.0 million recorded in 2025.
  • Peak YoY movement for Receivables: surged 272.51% in 2024, then increased 16.8% in 2025.
  • A 3-year view of Receivables shows it stood at $603480.0 in 2023, then soared by 272.51% to $2.2 million in 2024, then rose by 25.69% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Receivables are $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $1.9 million (Q2 2025).